M&T Bank’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-22,941
Closed -$58K 1786
2016
Q4
$58K Sell
22,941
-292
-1% -$838 ﹤0.01% 1566
2016
Q3
$72K Hold
23,233
﹤0.01% 1569
2016
Q2
$75K Hold
23,233
﹤0.01% 1542
2016
Q1
$72K Hold
23,233
﹤0.01% 1581
2015
Q4
$93K Buy
+23,233
New +$107K ﹤0.01% 1583

Other funds holding ECYT

M&T Bank's ECYT Position: Q1 2017 in Review

M&T Bank sold out of Endocyte, Inc. Common Stock (ECYT) in Q1 2017, closing a stake of 22,941 shares — an estimated $58K sold.

M&T Bank first reported a position in ECYT in Q4 2015 and held it in 5 quarters. The position peaked at $93K in Q4 2015. 82 funds tracked by Wall St. Rank hold ECYT as of Q1 2017.

  • M&T Bank reported no remaining Endocyte, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • M&T Bank sold 22,941 Endocyte, Inc. Common Stock shares in Q1 2017, an estimated $58K.
  • M&T Bank first reported a position in Endocyte, Inc. Common Stock in Q4 2015 and held it in 5 quarters.
  • M&T Bank's Endocyte, Inc. Common Stock position peaked at $93K in Q4 2015.
  • 82 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q1 2017.

Based on M&T Bank's 13F filing for Q1 2017, filed 10 May 2017.